<p>— EXPAREL is the only FDA-approved single-dose regional analgesic to safely demonstrate four days of superiority versus bupivacaine in two clinical studies — — New indications for use as an
<ul><li>Prior 43.2</li></ul><p>Swiss manufacturing conditions improved in June but it still marks a contraction towards the end of Q2. This is the sixth month running tha
Leave a Comment